Comparative evaluation of antiproliferative activity and induction of apoptosis by some fluoroquinolones with a human non-small cell lung cancer cell line in culture

Asian Pacific Journal of Cancer Prevention

Volumn 5, Issue 2, 2004, Pages 196-204

  Mondal, E R ^a   Das, S K ^a   Mukherjee, P ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Apoptosis; Fluoroquinolones; Growth inhibition; NCI H460 cell line

Indexed keywords

CIPROFLOXACIN; ENOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EVALUATION; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXACIN; EVALUATION STUDIES; FLUOROQUINOLONES; HUMANS; LUNG; LUNG NEOPLASMS; NORFLOXACIN; OFLOXACIN; PROBABILITY; REFERENCE VALUES;

EID: 4344629750     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aranha O, David P, Wood Jr, Sarkar FH (2000). Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res, 6, 891-900.
2. Averbuch SD (2002). Lung cancer prevention: Retonoids and the epidermal growth factor receptor- A phoenix rising. Clin Cancer Res, 8, 1-3.
3. Bratton SB, MacFarlane M, Cain K, Cohen GM (2000). Protein complexes activate distinct caspase cascades in death receptor and stress induced apoptosis. Exp Cell Res, 256, 27-33.
4. Chen AY, Liu LF (1994). DNA topoisomerases: essential enzymes and lethal targets. Ann Rev Pharmacol Toxicol, 34, 191-218.
5. Davis SM, Robson CN, Davies SL, Hickson ID (1988). Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cell to intercalating agents and epipodophyllotoxins. J Biol Chem, 263, 17724-9.
6. Dion LD, Blalock JE, Gifford GE (1977). Vitamin A- induced density dependent inhibition of L-cell proliferation. J Natl Cancer Inst, 58, 795-801.
7. Ebisuno S, Inagaki T, Kohjimoto Y, Ohkawa T (1997). The cytotoxic effect of fleroxacin and ciprofloxacin on a transitional cell carcinoma in vitro. Cancer, 80, 2263-7.
8. Herold C, Ocker M, Ganslmayer M, et al (2002). Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer, 86, 443-8.
9. Hussy P, Maass S, Tummler B, Gross F, Shomberg V (1986). Effects of 4-quinolones and novobiocin on calf thymus DNA polymerase á complex, topoisomerase I and II and growth of mammalian lymphoblasts. Antimicrob Agents Chemother, 29, 1073-8.
10. Hwang J, Hwang C-L (1994). Cellular regulation of mammalian DNA topoisomerases. In: Liu L F, editor. DNA topoisomerases biochemistry and molecular biology. Academic Press, New York pp 167-189
11. Jetten AM (1981). Action of retinoids and phorbal esters on cell growth and the binding of epidermal growth factor. Ann N Y Acad Sci, 359, 200-17.
12. Joseph B, Marchetti D, Formstecher P, et al (2002). Mitochondrial dysfunction is an essential step for killing non-small cell lung carcinomas resistant to conventional treatment. Oncogene, 21, 65-77
13. Jurgensmeier JM, Xie Z, Deveraux Q, et al (1998). Bax directly induce release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA, 95, 4997-5002.
14. Kerr JFR, Winterford CM, Harmon V (1994). Apoptosis, Its significance in cancer and cancer therapy. Cancer, 73, 2013-6.
15. Mancini M, Anderson BO, Caldwell E, et al (1997). Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in human colon carcinoma cell line. J Cell Biol, 138, 449-69.
16. Monks A, Scudiero D, Skehan P, et al (1991). Feasibility of a highflux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst, 83, 757-66.
17. Mukherjee P, Das SK (1995). Action of retinoic acid on human glioblastoma-astrocytoma-14 cells in culture. Neoplasma, 42, 123-8.
18. Patt LM, Itava K, Hakomori SI (1978). Retinol-induced density dependent growth inhibition and changes in glycolipids and LETS. Nature, 273, 379-81.
19. Patterson MK Jr (1979). Measurement of growth and viability of cells in culture. In: Jakoby W B and Pastan I H, editors. Methods in Enzymology, Vol. LVIII.,, Academic Press, New York, London pp 141-152.
20. Sarkar R, Das SK (1997). Retinoic acid induced alteration of cell surface topography and other changes in an oral carcinoma cell line in culture. Neoplasma, 44, 37-43.
21. Seay TM, Peretsman ST, Dixon PS (1996). Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. J Urol, 155, 757-62.
22. Sharma AK, Khosla R, Kelaand AK, Mehta VL (1994). Fluoroquinolones: Antimicrobial agents of 90's. Indian J Pharmacol, 26, 249-61.
23. Smiley ST, Reers M, Mottola-Hartshorn C, et al (1991). Intracellular heterogeneity in mitochondrial membrane potential revealed by J-aggregate forming lipophilic cation JC-1. Proc Natl Acad Sci USA, 88, 3671-5.
24. Tolis C, Peters GJ, Ferreira CG, Pinedo HM, Giaccone G (1999). Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer, 35, 796-807.
25. Tormanen U (1999). Apoptosis in non-small cell carcinoma and preinvasive lesions of the lung. pp 25. (Thesis). Available at: http://herkules.oulu.fi/isbn9514253302
26. Yamakuchi M, Nakata M, Kamahara Ko-ichi, Kitajima I, Maruyama I (1997). New quinolones, ofloxacin and levofloxacin inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Lett, 119, 213-9.